 Home > Active Ingredient News > Drugs Articles > Novartis's $20.7 billion sale of Roche's equity may be used to acquire Alnylam

Novartis's $20.7 billion sale of Roche's equity may be used to acquire Alnylam

 Last Update: 2021-12-06
 Source: Internet
 Author: User

Tags

otc gene

roche

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Novartis obtained a large amount of cash by selling its 20-year stake in Roche, sparking media speculation about where the company will spend the money

The biotechnology company based in Cambridge, Massachusetts, is the developer of RNA interference (RNAi) technology behind Novartis’s newly acquired cholesterol drug Leqvio (also known as inclisiran), which is expected to soon be approved by the US FDA

In a conference call in July of this year, when asked about comments on the possible pursuit of mRNA, Novartis CEO Vas Narasimhan pointed out that the drugmaker is making continuous efforts in RNAi

The cooperation between Novartis and Alnylam can also be traced back a long time ago

Alnylam successfully launched Onpattro in 2018 as the first RNAi therapy approved by the FDA

In addition, Alnylam is currently in the transitional period of CEO, long-term leader John Maragonore handed over the position to President and Chief Operating Officer Yvonne Greenstreet

In addition to Alnylam, Novartis may also conduct transactions in other areas.

Gene therapy company BioMarin Pharmaceutical is also one of the most attractive potential acquisition targets

Original English: https:// href="https://" target="_blank">https://

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

N-Methyl-L-alanine3913-67-5

CAS No.: 3913-67-5

Industrial Grade

$1-1.04/KG FOB

High Purity 99% PEG MGF CAS 108174-48-7 Customized Peptides from China OUDA

CAS No.: 108174-48-7

Pharmacy Grade

$2-2.6/G FOB

Wholesales Purity 99 Peptides Powder Sema Tirz Retatrutide 5mg/10mg/15mg to Door From China

CAS No.: 2023788-19-2

Pharmacy Grade

$150-180/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.